KC
Kevin Caliendo UBS Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
26
Teva Pharmaceuticals
TEVA
$21.7B
| $18.95 | $11 |
42%
downside
| Neutral | 4 years ago |
|